Reduced effectiveness of ganciclovir.
Maribavir should not be given with ganciclovir.
Source: Harrison 22e · unknown
Antiviral agent for CMV (benzimidazole)
Maribavir is a benzimidazole that inhibits the CMV UL97 protein kinase and CMV replication, and reduces the egress of viral particles from the nucleus.
Reduced effectiveness of ganciclovir.
Maribavir should not be given with ganciclovir.
Source: Harrison 22e · unknown
Increased plasma levels of cyclosporine.
Monitoring and potential dose adjustment of cyclosporine may be required.
Source: Harrison 22e · unknown
Increased plasma levels of everolimus.
Monitoring and potential dose adjustment of everolimus may be required.
Source: Harrison 22e · unknown
Increased plasma levels of sirolimus.
Monitoring and potential dose adjustment of sirolimus may be required.
Source: Harrison 22e · unknown
Increased plasma levels of tacrolimus.
Monitoring and potential dose adjustment of tacrolimus may be required.
Source: Harrison 22e · unknown
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team